Lettieri Corrado, Buffoli Francesca, Romano Michele, Aroldi Marco, Baccaglioni Nicola, Tomasi Luca, Rosiello Renato, Agostini Francesco, Kuwornu Helène, Pepi Patrizia, Izzo Antonio, Zanini Roberto
Dipartimento di Cardiologia, A.O. Carlo Poma, Mantova.
Ital Heart J Suppl. 2005 Sep;6(9):588-98.
As a consequence of prolonged life expectancy the number of older patients with symptomatic coronary artery disease is constantly increasing. The aim of the study was to evaluate procedural success, immediate and long-term outcomes and the predictive factors of prognosis in patients aged > 80 years with high-risk coronary artery disease treated with coronary angioplasty.
In this retrospective study, we report the diagnostic and therapeutic strategies adopted in patients aged > 80 years admitted to our institution for acute coronary syndrome with or without ST-segment elevation or disabling angina (CCS class 3-4) and the immediate and long-term results of patients treated with coronary angioplasty.
A conservative approach was adopted in 180 patients (33%, group 1) out of the total number of 545 patients, while 365 patients (67%, group 2) underwent coronary angiography. Among these, 85% underwent revascularization. Relevant comorbidities were significantly higher in group 1 (59 vs 16%, p < 0.001) while a clinical presentation with ST-elevation myocardial infarction was prevalent in group 2 (15 vs 6%, p = 0.007). The in-hospital mortality was 19% in group 1 and 7.9% in group 2 (p = 0.001). Among 198 patients treated with angioplasty, procedural success was achieved in 93% of cases, with 8% in-hospital mortality. Periprocedural myocardial infarction occurred in 3.3% and major bleeding in 5.6% of patients. At multivariate analysis ST-elevation myocardial infarction and cardiogenic shock were significantly related to the in-hospital mortality. At follow-up (mean 25 +/- 13 months) 13 patients died, 9 from cardiac causes and 4 from noncardiac events. Recurrence of ischemia requiring revascularization occurred in 15.9% of cases. Cumulative survival at follow-up was respectively 86% at 1 year and 83% at 5 years, while the event-free survival at 5 years was 59% in the entire group, without any significant difference among patients with multivessel disease in whom a complete vs an incomplete revascularization was performed. The presence of severe comorbidities appeared to be the only predictive factor of unfavorable outcome at long-term follow-up at multivariate analysis.
In patients aged > 80 years with symptomatic ischemic heart disease at high risk, the invasive approach was prevalent. Higher mortality rates were found in patients in whom coronary angiography was not performed. Comorbidities represent an important negative prognostic factor, impairing both the possibility of an invasive approach and conditioning an unfavorable outcome of revascularized patients. Coronary angioplasty can be successfully performed even in elderly patients. The in-hospital mortality turns out significantly higher in the setting of an acute ST-elevation myocardial infarction or in cardiogenic shock patients. For patients overcoming the acute phase, high survival rates can be expected at follow-up.
由于预期寿命延长,有症状的冠状动脉疾病老年患者数量持续增加。本研究旨在评估接受冠状动脉成形术治疗的80岁以上高危冠状动脉疾病患者的手术成功率、近期和长期预后以及预后的预测因素。
在这项回顾性研究中,我们报告了因急性冠状动脉综合征(伴或不伴ST段抬高)或失能性心绞痛(加拿大心血管学会分级3 - 4级)入住我院的80岁以上患者所采用的诊断和治疗策略,以及接受冠状动脉成形术患者的近期和长期结果。
在545例患者中,180例(33%,第1组)采用了保守治疗方法,而365例(67%,第2组)接受了冠状动脉造影。其中,85%的患者接受了血运重建。第1组的相关合并症显著更高(59%对16%,p < 0.001),而第2组以ST段抬高型心肌梗死为临床表现更为常见(15%对6%,p = 0.007)。第1组的住院死亡率为19%,第2组为7.9%(p = 0.001)。在198例接受成形术治疗的患者中,93%的病例手术成功,住院死亡率为8%。围手术期心肌梗死发生率为3.3%,主要出血发生率为5.6%。多因素分析显示,ST段抬高型心肌梗死和心源性休克与住院死亡率显著相关。随访(平均25 ± 13个月)期间,13例患者死亡,9例死于心脏原因,4例死于非心脏事件。15.9%的病例出现需要血运重建的缺血复发。随访时1年累计生存率分别为86%,5年为83%,而整个组5年无事件生存率为59%,在接受完全血运重建与不完全血运重建的多支血管疾病患者之间无显著差异。多因素分析显示,严重合并症的存在似乎是长期随访不良结局的唯一预测因素。
在80岁以上有症状的高危缺血性心脏病患者中,侵入性治疗方法较为普遍。未进行冠状动脉造影的患者死亡率较高。合并症是一个重要的负面预后因素,既影响侵入性治疗方法的可能性,又影响血运重建患者的不良结局。即使在老年患者中也可以成功进行冠状动脉成形术。在急性ST段抬高型心肌梗死或心源性休克患者中,住院死亡率显著更高。对于度过急性期的患者,随访时可预期较高的生存率。